Cyclin E1 Amplification Confers Sensitivity to Proteasome Inhibition

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2013-256
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Reduction of Cdc25A Contributes to Cyclin E1-Cdk2 Inhibition at Senescence in Human Mammary Epithelial Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

SMARCA2-deficiency Confers Sensitivity to Targeted Inhibition of SMARCA4 in Esophageal Squamous Cell Carcinoma Cell Lines

Scientific Reports
Multidisciplinary
2019English

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

DPP6A Confers Redox Sensitivity to Kv4 Channel Inactivation

Biophysical Journal
Biophysics
2012English

Inhibition of Proteasome Deubiquitinase Activity: A Strategy to Overcome Resistance to Conventional Proteasome Inhibitors?

Drug Resistance Updates
Cancer ResearchOncologyInfectious DiseasesPharmacology
2015English

BRD4 Amplification Facilitates an Oncogenic Gene Expression Program in High-Grade Serous Ovarian Cancer and Confers Sensitivity to BET Inhibitors

PLoS ONE
Multidisciplinary
2018English

Cell-Specific Kaiso (ZBTB33) Regulation of Cell Cycle Through Cyclin D1 and Cyclin E1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

SPOP Suppresses Prostate Cancer Through Regulation of CYCLIN E1 Stability

Cell Death and Differentiation
Cell BiologyMolecular Biology
2018English

Combined Autophagy and Proteasome Inhibition

Autophagy
Cell BiologyMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy